Aktieanalys

Ortoma: Leveraging the positive outcome of OTS™ in Japan - Redeye

Redeye Publicerad: 21 Nov 2023 11:55

Redeye is encouraged by the news that Ortoma continues to be active in the Japanese market and leverage the existing agreement with Johnson & Johnson within OTS™ Hip with a Memorandum of Understanding for the OTS™ Knee. This follows that Ortoma has successfully met the high standards in the Japanese market for OTS™ Hip. The agreement covers both OTS™ Plan and Guide and aims to evaluate the market requirements in Japan and define an extended version. The MoU also includes a negotiation period for the distribution rights in Japan with exclusive rights while the evaluation and negotiation for the distribution rights for Japan.

Länk till analysen i sin helhet: https://www.redeye.se/research/962022/ortoma-leveraging-the-positive-outcome-of-ots-in-japan?utm_source=finwire&utm_medium=RSS

Nyheter om Ortoma

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!